{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,13]],"date-time":"2026-06-13T08:56:24Z","timestamp":1781340984123,"version":"3.54.1"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T00:00:00Z","timestamp":1762905600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T00:00:00Z","timestamp":1762905600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Thromb Thrombolysis"],"DOI":"10.1007\/s11239-025-03207-x","type":"journal-article","created":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T13:14:12Z","timestamp":1762953252000},"page":"902-916","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Modern anticoagulation strategies in cardiovascular surgery: nonvitamin K antagonist oral anticoagulants versus warfarin after aortic bioprosthetic valve replacement"],"prefix":"10.1007","volume":"59","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3995-3012","authenticated-orcid":false,"given":"Moiuz","family":"Chaudhri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed Dawood Al","family":"Mahrizi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. Aiman","family":"Nadeem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda","family":"Canal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pranesh","family":"Rajendran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vindhya Rani","family":"Rapelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harman","family":"Gill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barira","family":"Haroon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Areej","family":"Shahzad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frederick","family":"Acquah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Kaunzinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chonyang","family":"Albert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad Rehan","family":"Raza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,12]]},"reference":[{"issue":"9","key":"3207_CR1","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1016\/j.repc.2024.02.013","volume":"43","author":"H Costa","year":"2024","unstructured":"Costa H, Cust\u00f3dio P, Baptista Gon\u00e7alves R, Magro L, P., Sousa Uva M (2024) Non-vitamin K versus vitamin K antagonist oral anticoagulants in surgical mitral valve repair or bioprosthetic valve replacement in the first three months after surgery. Revista Portuguesa De Cardiologia: Orgao Oficial Da Sociedade Portuguesa De Cardiologia = Portuguese J Cardiol : Official J Portuguese Soc Cardiol 43(9):501\u2013509. https:\/\/doi.org\/10.1016\/j.repc.2024.02.013","journal-title":"Revista Portuguesa De Cardiologia: Orgao Oficial Da Sociedade Portuguesa De Cardiologia = Portuguese J Cardiol : Official J Portuguese Soc Cardiol"},{"issue":"6","key":"3207_CR2","doi-asserted-by":"publisher","first-page":"2340","DOI":"10.21037\/jtd.2019.06.04","volume":"11","author":"K Bartus","year":"2019","unstructured":"Bartus K, Sadowski J, Litwinowicz R, Filip G, Jasinski M, Deja M, Kusmierczyk M, Pawlak S, Jemielity M, Jagielak D, Hendzel P, Suwalski P, Tobota Z, Maruszewski B, Kapelak B (2019) Changing trends in aortic valve procedures over the past ten years-from mechanical prosthesis via stented bioprosthesis to TAVI procedures-analysis of 50,846 aortic valve cases based on a Polish National cardiac surgery database. J Thorac Dis 11(6):2340\u20132349. https:\/\/doi.org\/10.21037\/jtd.2019.06.04","journal-title":"J Thorac Dis"},{"issue":"5","key":"3207_CR3","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1016\/0735-1097(94)00563-6","volume":"25","author":"M Heras","year":"1995","unstructured":"Heras M, Chesebro JH, Fuster V, Penny WJ, Grill DE, Bailey KR, Danielson GK, Orszulak TA, Pluth JR, Puga FJ (1995) High risk of thromboemboli early after bioprosthetic cardiac valve replacement. J Am Coll Cardiol 25(5):1111\u20131119. https:\/\/doi.org\/10.1016\/0735-1097(94)00563-6","journal-title":"J Am Coll Cardiol"},{"key":"3207_CR4","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.thromres.2016.11.021","volume":"150","author":"S Rafiq","year":"2017","unstructured":"Rafiq S, Steinbr\u00fcchel DA, Lille\u00f8r NB, M\u00f8ller CH, Lund JT, Thiis JJ, K\u00f8ber L, Olsen PS (2017) Antithrombotic therapy after bioprosthetic aortic valve implantation: warfarin versus aspirin, a randomized controlled trial. Thromb Res 150:104\u2013110. https:\/\/doi.org\/10.1016\/j.thromres.2016.11.021","journal-title":"Thromb Res"},{"key":"3207_CR5","doi-asserted-by":"publisher","unstructured":"Otto CM, Nishimura RA, Bonow RO, Carabello BA, Erwin JP 3rd, Gentile F, Jneid H, Krieger EV, Mack M, McLeod C, O\u2019Gara PT, Rigolin VH, Sundt TM 3rd, Thompson A, Toly C (2021) 2020 ACC\/AHA guideline for the management of patients with valvular heart disease: executive summary: a report of the American college of cardiology\/American heart association joint committee on clinical practice guidelines. Circulation 143(5):e35\u2013e71. https:\/\/doi.org\/10.1161\/CIR.0000000000000932","DOI":"10.1161\/CIR.0000000000000932"},{"key":"3207_CR6","doi-asserted-by":"publisher","unstructured":"Vahanian A, Beyersdorf F, Praz F, Milojevic M, Baldus S, Bauersachs J, Capodanno D, Conradi L, De Bonis M, De Paulis R, Delgado V, Freemantle N, Gilard M, Haugaa KH, Jeppsson A, J\u00fcni P, Pierard L, Prendergast BD, S\u00e1daba JR, Tribouilloy C, ESC\/EACTS Scientific Document Group (2022) 2021 ESC\/EACTS guidelines for the management of valvular heart disease. Eur Heart J 43(7):561\u2013632. https:\/\/doi.org\/10.1093\/eurheartj\/ehab395","DOI":"10.1093\/eurheartj\/ehab395"},{"issue":"5","key":"3207_CR7","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1002\/clc.23178","volume":"42","author":"PO Guimar\u00e3es","year":"2019","unstructured":"Guimar\u00e3es PO, Pokorney SD, Lopes RD, Wojdyla DM, Gersh BJ, Giczewska A, Carnicelli A, Lewis BS, Hanna M, Wallentin L, Vinereanu D, Alexander JH, Granger CB (2019) Efficacy and safety of apixaban vs warfarin in patients with atrial fibrillation and prior bioprosthetic valve replacement or valve repair: insights from the ARISTOTLE trial. Clin Cardiol 42(5):568\u2013571. https:\/\/doi.org\/10.1002\/clc.23178","journal-title":"Clin Cardiol"},{"issue":"1","key":"3207_CR8","doi-asserted-by":"publisher","DOI":"10.1093\/icvts\/ivac112","volume":"35","author":"M Milojevic","year":"2022","unstructured":"Milojevic M, Nikolic A, Micovic S, Jeppsson A (2022) Oral anticoagulation following bioprosthetic SAVR in patients with atrial fibrillation: what\u2019s the current status of noacs? Interact Cardiovasc Thorac Surg 35(1):ivac112. https:\/\/doi.org\/10.1093\/icvts\/ivac112","journal-title":"Interact Cardiovasc Thorac Surg"},{"key":"3207_CR9","doi-asserted-by":"publisher","first-page":"n71","DOI":"10.1136\/bmj.n71","volume":"372","author":"MJ Page","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, Shamseer L, Tetzlaff JM, Akl EA, Brennan SE, Chou R, Glanville J, Grimshaw JM, Hr\u00f3bjartsson A, Lalu MM, Li T, Loder EW, Mayo-Wilson E, McDonald S, McGuinness LA, Moher D (2021) The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ 372:n71. https:\/\/doi.org\/10.1136\/bmj.n71","journal-title":"BMJ"},{"key":"3207_CR10","unstructured":"Sch\u00fcnemann H, Bro\u017cek J, Guyatt G, Oxman A (eds) (2013) GRADE handbook for grading quality of evidence and strength of recommendations. Updated October 2013. The GRADE Working Group, Available from guidelinedevelopment.org\/handbook"},{"issue":"1","key":"3207_CR11","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1093\/ehjcvp\/pvz064","volume":"7","author":"JH Butt","year":"2021","unstructured":"Butt JH, De Backer O, Olesen JB, Gerds TA, Havers-Borgersen E, Gislason GH, Torp-Pedersen C, S\u00f8ndergaard L, K\u00f8ber L, Fosb\u00f8l EL (2021) Vitamin K antagonists vs. direct oral anticoagulants after transcatheter aortic valve implantation in atrial fibrillation. Eur Heart J 7(1):11\u201319. https:\/\/doi.org\/10.1093\/ehjcvp\/pvz064","journal-title":"Eur Heart J"},{"issue":"29","key":"3207_CR12","doi-asserted-by":"publisher","first-page":"2783","DOI":"10.1093\/eurheartj\/ehac242","volume":"43","author":"JP Collet","year":"2022","unstructured":"Collet JP, Van Belle E, Thiele H, Berti S, Lhermusier T, Manigold T, Neumann FJ, Gilard M, Attias D, Beygui F, Cequier A, Alfonso F, Aubry P, Baronnet F, Ederhy S, Kasty ME, Kerneis M, Barthelemy O, Lef\u00e8vre T, Leprince P, ATLANTIS Investigators of the ACTION Group (2022) Apixaban vs. standard of care after transcatheter aortic valve implantation: the ATLANTIS trial. Eur Heart J 43(29):2783\u20132797. https:\/\/doi.org\/10.1093\/eurheartj\/ehac242","journal-title":"Eur Heart J"},{"issue":"15","key":"3207_CR13","doi-asserted-by":"publisher","first-page":"1704","DOI":"10.1016\/j.jcin.2021.05.025","volume":"14","author":"R Didier","year":"2021","unstructured":"Didier R, Lhermusier T, Auffret V, Eltchaninoff H, Le Breton H, Cayla G, Commeau P, Collet JP, Cuisset T, Dumonteil N, Verhoye JP, Beurtheret S, Lef\u00e8vre T, Teiger E, Carri\u00e9 D, Himbert D, Albat B, Cribier A, Sudre A, Blanchard D, France-TAVI (2021) TAVR patients requiring anticoagulation: direct oral anticoagulant or vitamin K antagonist? JACC Cardiovasc Intervent 14(15):1704\u20131713. https:\/\/doi.org\/10.1016\/j.jcin.2021.05.025","journal-title":"JACC Cardiovasc Intervent"},{"issue":"2","key":"3207_CR14","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1056\/NEJMoa1911425","volume":"382","author":"GD Dangas","year":"2020","unstructured":"Dangas GD, Tijssen JGP, W\u00f6hrle J, S\u00f8ndergaard L, Gilard M, M\u00f6llmann H, Makkar RR, Herrmann HC, Giustino G, Baldus S, De Backer O, Guimar\u00e3es AHC, Gullestad L, Kini A, von Lewinski D, Mack M, Moreno R, Sch\u00e4fer U, Seeger J, Tch\u00e9tch\u00e9 D, GALILEO Investigators (2020) A controlled trial of Rivaroxaban after transcatheter aortic-valve replacement. N Engl J Med 382(2):120\u2013129. https:\/\/doi.org\/10.1056\/NEJMoa1911425","journal-title":"N Engl J Med"},{"issue":"3","key":"3207_CR15","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1007\/s10840-020-00833-8","volume":"61","author":"L Di Biase","year":"2021","unstructured":"Di Biase L, Romero J, Briceno D, Lakkireddy D, Trivedi C, Mohanty P, Mohanty S, Horton R, Hranitzky P, Gallinghouse GJ, Alviz I, Turagam M, Gopinathannair R, Della Rocca DG, Beheiry S, Burkhardt JD, Viles-Gonzales J, Natale A (2021) Periprocedural and long-term safety and feasibility of direct oral anticoagulants in patients with biological valve undergoing radiofrequency catheter ablation for atrial fibrillation: a prospective multicenter study. J Interv Card Electrophysiol 61(3):617\u2013622. https:\/\/doi.org\/10.1007\/s10840-020-00833-8","journal-title":"J Interv Card Electrophysiol"},{"issue":"13","key":"3207_CR16","doi-asserted-by":"publisher","first-page":"e1066","DOI":"10.4244\/EIJ-D-22-00521","volume":"18","author":"N Mangner","year":"2023","unstructured":"Mangner N, Brinkert M, Keller LS, Moriyama N, Hagemeyer D, Haussig S, Crusius L, Kobza R, Abdel-Wahab M, Laine M, Stortecky S, Pilgrim T, Nietlispach F, Ruschitzka F, Thiele H, Toggweiler S, Linke A (2023) Continued non-vitamin K antagonist oral anticoagulants versus vitamin K antagonists during transcatheter aortic valve implantation. EuroIntervention 18(13):e1066\u2013e1076. https:\/\/doi.org\/10.4244\/EIJ-D-22-00521","journal-title":"EuroIntervention"},{"issue":"1","key":"3207_CR17","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.athoracsur.2021.03.016","volume":"113","author":"VA Mannacio","year":"2022","unstructured":"Mannacio VA, Mannacio L, Antignano A, Mauro C, Mastroroberto P, Musumeci F, Zebele C, Iannelli G (2022) New oral anticoagulants versus warfarin in atrial fibrillation after early postoperative period in patients with bioprosthetic aortic valve. Ann Thorac Surg 113(1):75\u201382. https:\/\/doi.org\/10.1016\/j.athoracsur.2021.03.016","journal-title":"Ann Thorac Surg"},{"issue":"17","key":"3207_CR18","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.122.026666","volume":"11","author":"A Mentias","year":"2022","unstructured":"Mentias A, Saad M, Michael M, Nakhla S, Menon V, Harb S, Chaudhury P, Johnston D, Saliba W, Wazni O, Svensson L, Desai MY, Kapadia S (2022) Direct oral anticoagulants versus warfarin in patients with atrial fibrillation and valve replacement or repair. J Am Heart Assoc 11(17):e026666. https:\/\/doi.org\/10.1161\/JAHA.122.026666","journal-title":"J Am Heart Assoc"},{"issue":"9","key":"3207_CR19","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1007\/s00392-018-1247-x","volume":"107","author":"NA Geis","year":"2018","unstructured":"Geis NA, Kiriakou C, Chorianopoulos E, Uhlmann L, Katus HA, Bekeredjian R (2018) NOAC monotherapy in patients with concomitant indications for oral anticoagulation undergoing transcatheter aortic valve implantation. Clin Res Cardiology: Official J German Cardiac Soc 107(9):799\u2013806. https:\/\/doi.org\/10.1007\/s00392-018-1247-x","journal-title":"Clin Res Cardiology: Official J German Cardiac Soc"},{"issue":"9","key":"3207_CR20","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1007\/s40261-020-00939-x","volume":"40","author":"S Pasciolla","year":"2020","unstructured":"Pasciolla S, Zizza LF, Le T, Wright K (2020) Comparison of the efficacy and safety of direct oral anticoagulants and warfarin after bioprosthetic valve replacements. Clin Drug Investig 40(9):839\u2013845. https:\/\/doi.org\/10.1007\/s40261-020-00939-x","journal-title":"Clin Drug Investig"},{"issue":"1","key":"3207_CR21","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1007\/s10557-022-07381-5","volume":"38","author":"R Eikelboom","year":"2024","unstructured":"Eikelboom R, Whitlock RP, Sibilio S, Nguyen F, Perez R, Weitz JI, Belley-Cote E (2024) Direct oral anticoagulation versus warfarin in patients with atrial fibrillation and bioprosthetic heart valves: a retrospective, real-world cohort study. Cardiovasc Drugs Ther 38(1):109\u2013117. https:\/\/doi.org\/10.1007\/s10557-022-07381-5","journal-title":"Cardiovasc Drugs Ther"},{"issue":"4","key":"3207_CR22","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1055\/s-0037-1615261","volume":"44","author":"V Russo","year":"2018","unstructured":"Russo V, Attena E, Mazzone C, Esposito F, Parisi V, Bancone C, Rago A, Nigro G, Sangiuolo R, Onofrio D, A (2018) Nonvitamin K antagonist oral anticoagulants use in patients with atrial fibrillation and bioprosthetic heart valves\/Prior surgical valve repair: A multicenter clinical practice experience. Semin Thromb Hemost 44(4):364\u2013369. https:\/\/doi.org\/10.1055\/s-0037-1615261","journal-title":"Semin Thromb Hemost"},{"issue":"4","key":"3207_CR23","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCINTERVENTIONS.120.009963","volume":"14","author":"MW Sherwood","year":"2021","unstructured":"Sherwood MW, Gupta A, Vemulapalli S, Li Z, Piccini J, Harrison JK, Dai D, Vora AN, Mack MJ, Holmes DR, Rumsfeld JS, Cohen DJ, Thourani VH, Kirtane AJ, Peterson ED (2021) Variation in antithrombotic therapy and clinical outcomes in patients with preexisting atrial fibrillation undergoing transcatheter aortic valve replacement: insights from the society of thoracic Surgeons\/American college of cardiology transcatheter valve therapy registry. Circ Cardiovasc Interv 14(4):e009963. https:\/\/doi.org\/10.1161\/CIRCINTERVENTIONS.120.009963","journal-title":"Circ Cardiovasc Interv"},{"issue":"1","key":"3207_CR24","doi-asserted-by":"publisher","DOI":"10.1136\/openhrt-2024-002602","volume":"11","author":"EL Skogseid","year":"2024","unstructured":"Skogseid EL, Batra G, Westerbergh J, Held C, Christersson C (2024) Thromboembolic and bleeding events after valvular intervention in patients with atrial fibrillation. Open Heart 11(1):e002602. https:\/\/doi.org\/10.1136\/openhrt-2024-002602","journal-title":"Open Heart"},{"issue":"1","key":"3207_CR25","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.121.023561","volume":"11","author":"T Tanawuttiwat","year":"2022","unstructured":"Tanawuttiwat T, Stebbins A, Marquis-Gravel G, Vemulapalli S, Kosinski AS, Cheng A (2022) Use of direct oral anticoagulant and outcomes in patients with atrial fibrillation after transcatheter aortic valve replacement: insights from the STS\/ACC TVT registry. J Am Heart Assoc 11(1):e023561. https:\/\/doi.org\/10.1161\/JAHA.121.023561","journal-title":"J Am Heart Assoc"},{"key":"3207_CR26","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.ahj.2025.02.019","volume":"285","author":"T Ando","year":"2025","unstructured":"Ando T, Nazif T, Briasoulis A, Afonso L, Stebbins A, Marquis-Gravel G, Kosinski AS, Leon M, Vemulapalli S (2025) Clinical outcomes of direct oral anticoagulant versus warfarin after transcatheter aortic valve replacement: from the STS\/ACC TVT registry. Am Heart J 285:66\u201373. https:\/\/doi.org\/10.1016\/j.ahj.2025.02.019","journal-title":"Am Heart J"},{"issue":"12","key":"3207_CR27","doi-asserted-by":"publisher","first-page":"2549","DOI":"10.1016\/j.clinthera.2019.10.008","volume":"41","author":"V Russo","year":"2019","unstructured":"Russo V, Carbone A, Attena E, Rago A, Mazzone C, Proietti R, Parisi V, Scotti A, Nigro G, Golino P, D\u2019Onofrio A (2019) Clinical benefit of direct oral anticoagulants versus vitamin K antagonists in patients with atrial fibrillation and bioprosthetic heart valves. Clin Ther 41(12):2549\u20132557. https:\/\/doi.org\/10.1016\/j.clinthera.2019.10.008","journal-title":"Clin Ther"},{"issue":"22","key":"3207_CR28","doi-asserted-by":"publisher","first-page":"2117","DOI":"10.1056\/NEJMoa2029603","volume":"383","author":"HP Guimar\u00e3es","year":"2020","unstructured":"Guimar\u00e3es HP, Lopes RD, de Barros E, Silva PGM, Liporace IL, Sampaio RO, Tarasoutchi F, Hoffmann-Filho CR, Patriota deLS, Leiria R, Lamprea TLL, Precoma D, Atik DB, Silveira FA, Farias FS, Barreto FR, Almeida DO, Zilli AP, de Souza Neto AC, Cavalcante JD, Figueira MA, RIVER Trial Investigators (2020) Rivaroxaban in patients with atrial fibrillation and a bioprosthetic mitral valve. N Engl J Med 383(22):2117\u20132126. https:\/\/doi.org\/10.1056\/NEJMoa2029603","journal-title":"N Engl J Med"},{"issue":"2","key":"3207_CR29","doi-asserted-by":"publisher","first-page":"355","DOI":"10.5603\/CJ.a2021.0158","volume":"29","author":"M Piepiorka-Broniecka","year":"2022","unstructured":"Piepiorka-Broniecka M, Michalski TA, Figatowski T, Wojtowicz A, Jurowiecki J, Stanska A, Rogowski J, Jaguszewski MJ (2022) NOAC versus warfarin in the treatment of atrial fibrillation during the first three months after bioprosthetic aortic valve replacement. Cardiol J 29(2):355\u2013357. https:\/\/doi.org\/10.5603\/CJ.a2021.0158","journal-title":"Cardiol J"},{"key":"3207_CR30","doi-asserted-by":"publisher","DOI":"10.1007\/s10557-024-07585-x","author":"C Izumi","year":"2024","unstructured":"Izumi C, Amano M, Fukushima S, Yaku H, Eishi K, Sakaguchi T, Minami M, Yamamoto H, Onda K, Omae K (2024) Efficacy and safety of Edoxaban in anticoagulant therapy early after surgical bioprosthetic valve replacement: rationale and design of the ENBALV trial. Cardiovasc Drugs Ther. https:\/\/doi.org\/10.1007\/s10557-024-07585-xAdvance online publication","journal-title":"Cardiovasc Drugs Ther"},{"issue":"11","key":"3207_CR31","doi-asserted-by":"publisher","first-page":"1699","DOI":"10.1253\/circj.CJ-22-0226","volume":"86","author":"M Miyake","year":"2022","unstructured":"Miyake M, Takegami M, Obayashi Y, Amano M, Kitai T, Fujita T, Koyama T, Tanaka H, Ando K, Komiya T, Izumo M, Kawai H, Eishi K, Yoshida K, Kimura T, Nawada R, Sakamoto T, Shibata Y, Fukui T, Minatoya K, BPV-AF Registry Group (2022) Comparison of direct oral anticoagulants and warfarin in patients with atrial fibrillation and an aortic bioprosthetic valve. Circ J 86(11):1699\u20131707. https:\/\/doi.org\/10.1253\/circj.CJ-22-0226","journal-title":"Circ J"},{"issue":"6","key":"3207_CR32","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0268113","volume":"17","author":"I Moon","year":"2022","unstructured":"Moon I, Go TH, Kim JY, Kang DR, Sohn SH, Lee HJ, Choi JW, Park JB, Hwang HY, Kim HK, Kim YJ, Kim KH, Lee SP (2022) Effectiveness and safety of non-vitamin K direct oral anticoagulants in atrial fibrillation patients with bioprosthetic valve. PLoS One 17(6):e0268113. https:\/\/doi.org\/10.1371\/journal.pone.0268113","journal-title":"PLoS One"},{"key":"3207_CR33","doi-asserted-by":"publisher","unstructured":"Friedhelm Beyersdorf A, Vahanian M, Milojevic F, Praz S, Baldus J, Bauersachs D, Capodanno L, Conradi MD, Bonis R, De Paulis V, Delgado N, Freemantle M, Gilard KH, Haugaa A, Jeppsson P, J\u00fcni L, Pierard BD, Prendergast JR, S\u00e1daba C, Tribouilloy W, Wojakowski, ESC\/EACTS Scientific Document Group (2021), 2021 ESC\/EACTS Guidelines for the management of valvular heart disease: Developed by the Task Force for the management of valvular heart disease of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS), European Journal of Cardio-Thoracic Surgery, Volume 60, Issue 4, October Pages 727\u2013800. https:\/\/doi.org\/10.1093\/ejcts\/ezab389","DOI":"10.1093\/ejcts\/ezab389"},{"key":"3207_CR34","doi-asserted-by":"publisher","DOI":"10.1177\/10760296221103578","volume":"28","author":"R Ryu","year":"2022","unstructured":"Ryu R, Tran R (2022) DOACs in mechanical and bioprosthetic heart valves: a narrative review of emerging data and future directions. Clinical and Applied Thrombosis\/Hemostasis 28:10760296221103578. https:\/\/doi.org\/10.1177\/10760296221103578","journal-title":"Clinical and Applied Thrombosis\/Hemostasis"}],"container-title":["Journal of Thrombosis and Thrombolysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11239-025-03207-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11239-025-03207-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11239-025-03207-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,13]],"date-time":"2026-06-13T08:32:40Z","timestamp":1781339560000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11239-025-03207-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,12]]},"references-count":34,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2026,4]]}},"alternative-id":["3207"],"URL":"https:\/\/doi.org\/10.1007\/s11239-025-03207-x","relation":{},"ISSN":["1573-742X"],"issn-type":[{"value":"1573-742X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,12]]},"assertion":[{"value":"23 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}